220 related articles for article (PubMed ID: 16767161)
21. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress.
Kan CY; Petti C; Bracken L; Maritz M; Xu N; O'Brien R; Yang C; Liu T; Yuan J; Lock RB; MacKenzie KL
J Biol Chem; 2013 Apr; 288(17):12032-41. PubMed ID: 23449974
[TBL] [Abstract][Full Text] [Related]
23. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
24. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions.
Ramirez RD; Morales CP; Herbert BS; Rohde JM; Passons C; Shay JW; Wright WE
Genes Dev; 2001 Feb; 15(4):398-403. PubMed ID: 11230148
[TBL] [Abstract][Full Text] [Related]
25. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
26. Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization.
Kan CY; Wen VW; Pasquier E; Jankowski K; Chang M; Richards LA; Kavallaris M; MacKenzie KL
Oncogene; 2012 Nov; 31(46):4815-27. PubMed ID: 22310292
[TBL] [Abstract][Full Text] [Related]
27. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Wen VW; Wu K; Baksh S; Hinshelwood RA; Lock RB; Clark SJ; Moore MA; Mackenzie KL
Cancer Res; 2006 Nov; 66(22):10691-700. PubMed ID: 17108106
[TBL] [Abstract][Full Text] [Related]
28. UVA-induced epigenetic regulation of P16(INK4a) in human epidermal keratinocytes and skin tumor derived cells.
Chen IP; Henning S; Faust A; Boukamp P; Volkmer B; Greinert R
Photochem Photobiol Sci; 2012 Jan; 11(1):180-90. PubMed ID: 21986889
[TBL] [Abstract][Full Text] [Related]
29. Telomere dysfunction and inactivation of the p16(INK4a)/Rb pathway in pyothorax-associated lymphoma.
Tresnasari K; Takakuwa T; Ham MF; Rahadiani N; Nakajima H; Aozasa K
Cancer Sci; 2007 Jul; 98(7):978-84. PubMed ID: 17428253
[TBL] [Abstract][Full Text] [Related]
30. CREG1 enhances p16(INK4a) -induced cellular senescence.
Moolmuang B; Tainsky MA
Cell Cycle; 2011 Feb; 10(3):518-30. PubMed ID: 21263217
[TBL] [Abstract][Full Text] [Related]
31. Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral keratinocytes.
Cody DT; Huang Y; Darby CJ; Johnson GK; Domann FE
Oral Oncol; 1999 Sep; 35(5):516-22. PubMed ID: 10694953
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
33. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis].
Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081
[TBL] [Abstract][Full Text] [Related]
34. p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.
Sviderskaya EV; Gray-Schopfer VC; Hill SP; Smit NP; Evans-Whipp TJ; Bond J; Hill L; Bataille V; Peters G; Kipling D; Wynford-Thomas D; Bennett DC
J Natl Cancer Inst; 2003 May; 95(10):723-32. PubMed ID: 12759390
[TBL] [Abstract][Full Text] [Related]
35. Bmi-1 reduction plays a key role in physiological and premature aging of primary human keratinocytes.
Cordisco S; Maurelli R; Bondanza S; Stefanini M; Zambruno G; Guerra L; Dellambra E
J Invest Dermatol; 2010 Apr; 130(4):1048-62. PubMed ID: 19907431
[TBL] [Abstract][Full Text] [Related]
36. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
Prall F; Ostwald C; Weirich V; Nizze H
Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
[TBL] [Abstract][Full Text] [Related]
37. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
[TBL] [Abstract][Full Text] [Related]
38. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
39. Two mechanisms underlying the loss of p16(Ink4a) function are associated with distinct tumorigenic consequences for WS MEFs escaping from senescence.
Wu X; Jia S; Zhang X; Si X; Tang W; Luo Y
Mech Ageing Dev; 2012 Aug; 133(8):549-55. PubMed ID: 22813853
[TBL] [Abstract][Full Text] [Related]
40. p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells.
Herbert BS; Wright WE; Shay JW
Oncogene; 2002 Nov; 21(51):7897-900. PubMed ID: 12420227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
